Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Original Research

Published on 17 Aug 2022

Cardiac immune cell infiltration associates with abnormal lipid metabolism

in Lipids in Cardiovascular Disease

Vincenza Cifarelli
Ondrej Kuda
Kui Yang
Xinping Liu
Richard W. Gross
Terri A. Pietka
Gyu Seong Heo
Deborah Sultan
Hannah Luehmann
Josie Lesser

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.948332

5,429 views
3 citations

Case Report

Published on 16 Aug 2022

Pediatric patients with familially inherited sitosterolemia: Two case reports

in Lipids in Cardiovascular Disease

Shun-Qing Su
Di-Sheng Xiong
Xiu-Mei Ding
Jin-An Kuang
Yue-Chun Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.927267

2,858 views
5 citations

Original Research

Published on 16 Aug 2022

Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study

in Lipids in Cardiovascular Disease

Litong Qi
Jiyan Chen
Xiaodong Li
Xiaoyong Qi
Chunhua Ding
Xiaoping Chen
Xiang Gu
Wenliang Xiao
Shuiping Zhao
Yugang Dong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.888604

4,310 views
3 citations

Review

Published on 09 Aug 2022

Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues

in Lipids in Cardiovascular Disease

Roshni Bhatnagar
Neal M. Dixit
Eric H. Yang
Tamer Sallam

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.925816

10,901 views
25 citations

Original Research

Published on 09 Aug 2022

β-sheets in serum protein are independent risk factors for coronary lesions besides LDL-C in coronary heart disease patients

in Lipids in Cardiovascular Disease

Yu-lin Li
Jia-ying Xie
Bin Lu
Xiao-di Sun
Fang-fang Chen
Zhou-jie Tong
Wen-wen Sai
Wei Zhang
Zhi-hao Wang
Ming Zhong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.911358

2,992 views
1 citation

Case Report

Published on 08 Aug 2022

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia

in Lipids in Cardiovascular Disease

Kei Sasaki
Hayato Tada
Masa-aki Kawashiri
Toshimitsu Ito

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.942772

2,402 views
1 citation

Review

Published on 08 Aug 2022

Gender dimension in cardio-pulmonary continuum

in Lipids in Cardiovascular Disease

Leah Hernandez
Agne Laucyte-Cibulskiene
Liam J. Ward
Alexandra Kautzky-Willer
Maria-Trinidad Herrero
Colleen M. Norris
Valeria Raparelli
Louise Pilote
Peter Stenvinkel
Karolina Kublickiene

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.916194

6,760 views
3 citations

Study Protocol

Published on 04 Aug 2022

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

in Lipids in Cardiovascular Disease

Vivencio Barrios
Mar Castellanos
Raquel Campuzano Ruiz
Jorge Francisco Gómez Cerezo
Isabel Egocheaga Cabello
José M. Gámez
Icíar Martínez López
José María Mostaza
Nuria Morant Talamante
Javier Parrondo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.966049

5,120 views
7 citations

Original Research

Published on 27 Jul 2022

The relationship of remnant cholesterol and abdominal obesity in children: A cross-sectional study

in Lipids in Cardiovascular Disease

Jishuang Tong
Xinggui Li
Xiaoyue Liang
Fang Tang
Yanling Ren
Guang Hao
Xin Peng
Sunqing Luo
Ye Feng
Daochao Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.929560

2,628 views
9 citations

Original Research

Published on 26 Jul 2022

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease

in Lipids in Cardiovascular Disease

Shih-Wei Wang
Lung-Chih Li
Chung-Ming Fu
Yueh-Ting Lee
Hsiao-Ching Kuo
Chien-Ning Hsu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.887915

3,288 views
2 citations

Original Research

Published on 26 Jul 2022

An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome

in Lipids in Cardiovascular Disease

Sonia Ruiz-Bustillo
Neus Badosa
Ignacio Cabrera-Aguilera
Consol Ivern
Marc Llagostera
Diana Mojón
Miren Vicente
Núria Ribas
Lluis Recasens
Julio Martí-Almor

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.916031

2,348 views
2 citations

Original Research

Published on 15 Jul 2022

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)

in Lipids in Cardiovascular Disease

Isabella Sudano
Francois Mach
Tiziano Moccetti
Thilo Burkard
Christian Fahe
Alain Delabays
Hans Rickli
Pierre-Frédéric Keller
Jörn Dopheide
Sereina Bodenmann

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.953040

3,019 views
2 citations

Editorial

Published on 15 Jul 2022

Editorial: Insights in lipids in cardiovascular disease: 2021

in Lipids in Cardiovascular Disease

Irena Levitan
Tomas Vaisar

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.940153

1,731 views

Methods

Published on 14 Jul 2022

Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays

in Lipids in Cardiovascular Disease

Dean Oldham
Hong Wang
Juliet Mullen
Emma Lietzke
Kayla Sprenger
Philip Reigan
Robert H. Eckel
Kimberley D. Bruce

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.926631

4,387 views
9 citations

Original Research

Published on 11 Jul 2022

Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition

in Lipids in Cardiovascular Disease

Maojing Shi
Weibo Gao
Yuebo Jin
Jihong Zhu
Yuansheng Liu
Tianbing Wang
Chun Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.872523

7,922 views
10 citations

Original Research

Published on 07 Jul 2022

Dyslipidemia and the Prevalence of Hypertension: A Cross-Sectional Study Based on Chinese Adults Without Type 2 Diabetes Mellitus

in Lipids in Cardiovascular Disease

Wenke Cheng
Jingqi Zhuang
Siwei Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.938363

6,471 views
17 citations